In our research, we screened a panel of HER inhibitors and identified pyrotinib as a potent HER inhibitor that selectively suppresses the growth of GC with high EGFR gene copy number (CN) in vitro and in vivo. This evidence concerns the gene EGFR and gastric cancer.